FerGene

The list of companies that have made money out of a gene therapy is extremely short but Ferring Pharmaceuticals has a case for inclusion given the sales growth last year of its bladder cancer treatmen

Ferring Pharmaceuticals has been looking back at an eventful 2022 which saw potentially game-changing approvals in the US for its microbiome and gene therapies and record revenues for the Swiss group

The US FDA’s approval of Ferring Pharmaceuticals ’ bladder cancer gene therapy Adstiladrin just two weeks after the company took home an approval for the pioneering microbiome therapeutic Rebyota res

Just shy of three years after Ferring Pharmaceuticals and Blackstone formed FerGene to advance the late-stage bladder cancer gene therapy nadofaragene firadenovec, the pharma company and the priva